United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

hameln pharma ltd - calcium gluconate - solution for injection - 100mg/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

z & c krpan - calcium lactate pentahydrate, quantity: 199.732 mg/g (equivalent: calcium, qty 25.965 mg/g); magnesium citrate, quantity: 125.432 mg/g (equivalent: magnesium, qty 20.27 mg/g); stevia rebaudiana, quantity: 6.658 mg/g (equivalent: stevia rebaudiana, qty 66.577 mg/g); calcium carbonate, quantity: 66.577 mg/g (equivalent: calcium, qty 26.631 mg/g); zinc gluconate, quantity: 665.775 microgram/g (equivalent: zinc, qty 86.551 microgram/g); manganese sulfate monohydrate, quantity: 133.155 microgram/g (equivalent: manganese, qty 43.275 microgram/g); magnesium carbonate hydrate, quantity: 15.646 mg/g (equivalent: magnesium, qty 4.035 mg/g); aloe vera, quantity: 1.332 mg/g (equivalent: aloe vera, qty 266.31 mg/g; equivalent: hydroxyanthracene derivatives calculated as anhydrous barbaloin, qty 0.0133 mg/g); calcium ascorbate dihydrate, quantity: 2.663 mg/g (equivalent: calcium, qty 250.332 microgram/g; equivalent: ascorbic acid, qty 2.197 mg/g); dried magnesium sulfate, quantity: 21.478 mg/g (equivalent: magnesium, qty 2.663 mg/g); copper gluconate, quantity: 33.289 microgram/g (equivalent: copper, qty 4.66 microgram/g); calcium glycerophosphate, quantity: 73.635 mg/g (equivalent: calcium, qty 13.991 mg/g) - powder, oral - excipient ingredients: sodium bicarbonate; fructose; citric acid; flavour - maintain/support bone strength ; a diet deficient in calcium can lead to osteoporosis in later life. calcium may help prevent osteoporosis when dietary intake is inadequate ; decrease/reduce/relieve muscle cramps ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; soothe/calm nerves ; decrease/reduce/relieve symptoms of stress ; decrease/reduce/relieve symptoms of mild anxiety ; decrease/reduce/relieve sleeplessness ; decrease/reduce/relieve menstrual spasms/cramps ; decrease/reduce/relieve symptoms of premenstrual tension

United States - English - NLM (National Library of Medicine)

general injectables and vaccines, inc. - calcium gluconate monohydrate (unii: czn0mi5r31) (calcium cation - unii:2m83c4r6zb) - calcium gluconate monohydrate 98 mg in 1 ml - these highlights do not include all the information needed to use calcium gluconate injection safely and effectively. see full prescribing information for calcium gluconate injection.calcium gluconate injection, for intravenous use initial u.s. approval: 1941 calcium gluconate injection is indicationd for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia. limitations of use the safety of calcium gluconate injection for long term use has not been established. calcium gluconate injection is contraindicated in: - hypercalcemia - neonates (28 days of age or younger) receiving ceftriaxone [see warnings and precautions (5.2 )] 8.1 pregnancy risk summary limited available data with calcium gluconate injection use in pregnant women are insufficient to inform a drug associated risk of adverse developmental outcomes. there are risks to the mother and the fetus associated with hypocalcemia in pregnancy [see clinical considerations] . the estimated background risk of major birth defects an

Ireland - English - HPRA (Health Products Regulatory Authority)

dlrc pharma services limited - calcium chloride dihydrate - solution for injection - 10 percent weight/volume - calcium; calcium chloride

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - calcium gluconate monohydrate 100 mg/ml;   - solution for injection - 1000 mg/10ml - active: calcium gluconate monohydrate 100 mg/ml   excipient: calcium saccharate water for injection - parenteral administration of calcium gluconate is required in acute hypocalcaemia and hypocalcaemic tetany. it may be administered intravenously as an adjunct in the treatment of severe hyperkalaemia and as an aid in the treatment of depression due to overdose of magnesium sulphate (calcium is the antagonist of magnesium toxicity). intravenous injections of calcium have been used in the treatment of acute renal, biliary and intestinal colic. calcium has been used as an inotrope in cardiac resuscitation. calcium salts may also be used in the prevention of hypocalcaema in exchange transfusions and in long term electrolyte replacement therapy.

United States - English - NLM (National Library of Medicine)

american regent, inc. - calcium gluconate monohydrate (unii: czn0mi5r31) (calcium - unii:sy7q814vup) - calcium gluconate is used to treat conditions arising from calcium deficiencies such as hypocalcemic tetany, hypocalcemia related to hypoparathyroidism and hypocalcemia due to rapid growth or pregnancy. it is also used in the treatment of black widow spider bites to relieve muscle cramping and as an adjunct in the treatment of rickets, osteomalacia, lead colic and magnesium sulfate overdosage. calcium gluconate has also been employed to decrease capillary permeability in allergic conditions, nonthrombocytopenic purpura and exudative dermatoses such as dermatitis herpetiformis and for pruritus of eruptions caused by certain drugs. in hyperkalemia, calcium gluconate may aid in antagonizing the cardiac toxicity provided the patient is not receiving digitalis therapy. calcium salts are contraindicated in patients with ventricular fibrillation or hypercalcemia. intravenous administration of calcium is contraindicated when serum calcium levels are above normal. if neonates are required, or expected to require, trea

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - calcium gluconate monohydrate (unii: czn0mi5r31) (calcium cation - unii:2m83c4r6zb) - calcium gluconate injection is indicated for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia. limitations of use the safety of calcium gluconate injection for long term use has not been established. calcium gluconate injection is contraindicated in: - hypercalcemia - neonates (28 days of age or younger) receiving ceftriaxone [see warnings and precautions (5.2)] risk summary limited available data with calcium gluconate injection use in pregnant women are insufficient to inform a drug associated risk of adverse developmental outcomes. there are risks to the mother and the fetus associated with hypocalcemia in pregnancy [see clinical considerations] . the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. clinical considerations disease-associated maternal

United States - English - NLM (National Library of Medicine)

agrilabs - calcium gluconate (unii: sqe6vb453k) (calcium cation - unii:2m83c4r6zb) - calcium gluconate 23 g in 100 ml - to be used as an aid in the treatment of parturient paresis (milk fever) in cattle.

United States - English - NLM (National Library of Medicine)

animart - calcium gluconate (unii: sqe6vb453k) (calcium cation - unii:2m83c4r6zb) - calcium gluconate 23 g in 100 ml - for use in cattle as an aid in treating uncomplicated milk fever (parturient paresis).

Israel - English - Ministry of Health

nutrition consumer health - calcium (as carbonate) 700.7 mg; calcium (as lactate gluconate) 299.3 mg - tablet effervescent - calcium lactate gluconate - calcium supplement for states of calcium insufficiency, or requirement for calcium supplementation.